RBC Capital Maintains Outperform on Humana, Lowers Price Target to $265
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix maintains an Outperform rating on Humana (NYSE:HUM) but lowers the price target from $400 to $265.
October 08, 2024 | 2:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RBC Capital has maintained its Outperform rating on Humana but has significantly lowered the price target from $400 to $265, indicating a more cautious outlook.
The maintenance of an Outperform rating suggests continued confidence in Humana's performance, but the significant reduction in the price target from $400 to $265 indicates a more cautious outlook on the stock's potential upside. This mixed signal could lead to short-term downward pressure on the stock price as investors reassess their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100